INTRODUCTION

A
LCOHOLIC LIVER INJURY is a complex process involving several injury mechanisms and multiple cellular targets. (1) Several studies indicate that endotoxin and oxidative stress are important pathogenic mechanisms in alcohol-induced liver injury. (2) (3) (4) (5) It is well known that endotoxin is hepatotoxic and that concentrations of endotoxin are increased in alcoholic liver disease in experimental animals and humans. (2, 3, 6) One pathway by which endotoxemia and oxidative stress can cause liver injury is through activation of nuclear factor k B (NF-kB), which upregulates the production of proinflammatory cytokines, such as tumor necrosis factor-a (TNF-a) and interferon-g (IFNg). (7) (8) (9) A key molecule that upregulates TNF-a and IFN-g and promotes the inflammatory response is macrophage migration inhibitory factor (MIF). (10, 11) MIF was originally described as a lymphokine derived from activated T cells that inhibited the migration of macrophages. (12) Subsequently, it was shown that MIF is expressed in a variety of cells and tissues, including the liver. (10) Based on the information available about factors that stimulate expression of MIF, we hypothesized that MIF would be induced in experimental alcoholic liver disease (ALD). To evaluate the relationship between pathologic liver injury and expression of MIF, we used the rat intragastric feeding model for ALD. (13, 14) We and others have shown an inverse relationship between the saturation of lipids in the diet and the severity of alcohol-induced liver injury. (15, 16) Rats fed ethanol and a diet enriched in saturated fatty acids are protected from liver injury, (16) whereas diets enriched in polyunsaturated fatty acids promote alcoholic liver injury. (15) We and others have also shown that female rats are more susceptible to alcoholic liver injury than male rats and show more severe necrosis and inflammation. (17) Thus, the intragastric feeding model using male and female rats is useful to elucidate the relationship between pathologic changes in liver and proinflammatory mediators, such as MIF.
Our results show that necrosis and inflammation in ALD are associated with increased expression of MIF. The Kupffer cell and other mononuclear cells are the most likely source of MIF, although endothelial cells and hepatocytes also make a contribution. The upregulation of IFN-g and TNF-a in association with MIF also contributes to the inflammatory changes in alcoholic liver injury.
MATERIALS AND METHODS
Animals
Male Wistar rats weighing between 275 and 300 g were fed a liquid diet by continuous infusion through permanently implanted gastric tubes as described previously. (13, 14) The rats were given their total nutrient intake by intragastric infusion. The percentage of calories derived from fat was 35% of total calories. Vitamins and minerals were given as described previously. (14) The amount of ethanol was modified to maintain high levels of blood ethanol (150-300 mg/dl) throughout the day. The amount of ethanol was initially 10 g/kg/day and was increased to 16g/kg/day as tolerance developed. Each ethanol-fed rat had at least two measurements of blood alcohol.
In the first set of experiments, six groups of rats (5 rats per group) fed different dietary fats with ethanol or dextrose were studied. These groups were male rats fed medium-chain triglycerides plus dextrose (MCTD) or ethanol (MCTE) and fish oil plus dextrose (FD) or ethanol (FE). In addition, age-matched female rats were fed fish oil and dextrose (FFD) or ethanol (FFE). All control animals were pair-fed the same diet as ethanol-fed rats except that ethanol was isocalorically replaced by dextrose. All diets were prepared fresh daily. All animals were killed after 1 month of treatment with the experimental diets. When the animals were killed, a sample of liver was obtained for histopathologic analysis, and the rest of the liver was rapidly excised, washed with ice-cold 1.15% (w/v) KCl, and cut into small pieces. The liver specimens were transferred to plastic vials and placed in liquid nitrogen, and the vials were stored at 280°C. All animals received humane care in compliance with the National Institutes of Health criteria for care of laboratory animals.
In the second set of experiments, which were designed to evaluate the cellular source of MIF, IFN-g, and TNF-a mRNA, six groups of animals were evaluated (MCTD, MCTE, FD, FE, FFD, and FFE). All animals were killed after treatment with the experimental diets for 1 month.
Isolation of hepatocytes, Kupffer cells, and endothelial cells
Cells were isolated from anesthetized rats using procedures described previously (18) and isolation buffers described by Seglen. (19) Hepatocytes, Kupffer cells, and endothelial cells were isolated as previously described. (20) Briefly, after intravenous administration of sodium heparin (100 U), the livers were exsanguinated in situ by portal vein perfusion with Ca 21 -free buffer. Livers were excised, minced, and subsequently incubated in 0.05% collagenase in buffer. The different cell types were identified by morphology and immunohistochemical markers that included peroxidase, acid phosphatase, a 1 -antichymotrypsin, ED1, and cytokeratins. (21) Endothelial cells were the nonadherent cells from the Kupffer cell preparation and were placed onto type 1 collagen-coated dishes. The cells were stored at 270°C.
Histopathologic analysis
A small sample of the liver was obtained and formalin-fixed when the rats were killed. H & E stain was used for light microscopy. The severity of liver pathology was assessed as follows: steatosis (the percentage of liver cells containing fat) was scored 11 with ,25% of the cells containing fat, 21 with 26%-50% of the cells containing fat, 31 with 51%-75% of the cells containing fat, and 41 with .75% of the cells containing fat. Necrosis was quantified as the number of necrotic foci per square millimeter, and inflammation was scored as the number of inflammatory cells per square millimeter. At least three different sections were examined per sample of liver. The pathology was assessed blindly without knowledge of the experimental groups.
Measurement of blood alcohol
Blood was collected from the tail vein, and ethanol concentration was measured using an alcohol dehydrogenase kit from Sigma Chemical Co. (St. Louis, MO).
Measurement of conjugated dienes
Conjugated dienes in the total lipid extracted from liver homogenates were determined as described previously. (20) 
Measurement of plasma endotoxin
Endotoxin in plasma was measured as described previously (3) using the appropriate precautionary measures. (22) 
Analysis of mRNA for MIF, TNF-a, IFN-g, and b-actin by reverse transcriptase-polymerase chain reaction (RT-PCR)
To examine the expression of MIF, TNF-a, IFN-g, and bactin in liver tissue and cells, total RNA was isolated according to the guanidinium isothiocyanate method. (23) The integrity of RNA was assessed by agarose gel electrophoresis and ethidium bromide staining. RT-PCR was performed essentially as previously described. (20, 24) The sequences of primer pairs, 59 and 39, and predicted sizes of the amplified PCR fragments for MIF, TNF-a, IFN-g, and b-actin have been reported previously. (20, 25, 26 PCR products and molecular weight markers were subjected to electrophoresis on 1% agarose gels and visualized by means of ethidium bromide staining. The gels were analyzed by laser scanning densitometry using a Molecular Dynamics Densitometer and Image Quant software (Molecular Dynamics, Sunnyvale, CA). Each experiment included a negative control (sample RNA that had not been subjected to RT). Varying the number of PCR cycles did not change the relative differences between the samples, indicating that the PCR conditions were not within the plateau phase of amplification. All amplification reactions of one experiment were performed in parallel in the same heating block to ensure compatible conditions.
In situ hybridization and immunohistochemical analysis of MIF
In situ hybridization was performed on paraffin sections of formalin-fixed tissue with MIF antisense or sense cRNA probes as previously described. (27, 28) MIF protein expression was determined by immunostaining with the antimouse MIF monoclonal antibody (mAb). The specificity of the antisense probe and anti-MIF antibody was confirmed as described previously. (27, 28) In addition, some sections were also stained with the ED1 mAb using the peroxidase-antiperoxidase (PAP) method and counterstained with periodic acid-Schiff for immunohistochemical analysis of MIF. The sections were scored as previously described (10) 
Statistical analysis
All data are expressed as means 6 SD unless otherwise indicated. Statistical significance was evaluated using the unpaired Student's t-test for comparison between two means. Differences between more than 2 groups were analyzed using analysis of variance (ANOVA). Statistical significance was set at p , 0.05.
RESULTS
Some of the results, such as histopathologic findings, have been described previously for some of the animals included in other studies. (20, 24) There was no difference in weight gain 
Histopathology
The most severe pathology was seen in the male and female ethanol-fed rats (Table 1 ). In particular, the degree of necrosis and inflammation was much more severe in female rats. The male dextrose-fed rats showed no pathologic signs. In contrast, the female dextrose-fed rats had fatty liver, necrosis, and inflammation.
Enhanced expression of MIF and TNF-a and correlates with inflammatory changes, endotoxemia, and lipid peroxidation
We examined liver tissue for MIF by RT-PCR. MIF mRNA normalized using b-actin was detected in all experimental groups; However, the groups showing necrosis and inflammation and having increased levels of lipid peroxidation and endotoxin had the highest levels of MIF mRNA ( Fig. 1 and Table   2 ). Because MIF upregulates TNF-a and IFN-g, we also evaluated mRNA levels of these two cytokines in liver. Our results show that upregulation of TNF-a and IFN-g mRNA is similar to that seen with MIF in the different experimental groups (Fig. 1) .
Cellular origin of MIF mRNA
We next attempted to determine the cell type in liver responsible for increased MIF mRNA. Hepatocytes, Kupffer cells, and endothelial cells were isolated from the rats fed the different experimental diets. MIF mRNA was detected in all three cell types in all the groups. The highest levels of MIF mRNA were seen in all cell types in the fish oil-ethanol-fed male and female rats (Table 3) . Because the isolation procedure yields Kupffer and endothelial cells with 85%-90% purity, we cannot exclude the possibility that detectable levels of MIF mRNA in endothelial cells and hepatocytes in the rats exhibiting liver injury reflected contamination by Kupffer cells.
Increased MIF mRNA is associated with increased mRNA levels of TNF-a and IFN-g
Based on experimental evidence that MIF production can upregulate TNF-a and IFN-g synthesis and our observation that TNF-a and IFN-g are upregulated in conjunction with MIF in liver, we also determined TNF-a and IFN-g mRNA in the different cell types. Our results show that TNF-a and IFN-g are also increased in the same groups that show increased MIF (FE, FFD, FFE) ( Table 4 ). In contrast to the cellular expression of MIF that occurred in all three cell types, the increase in TNF-a and IFN-g was restricted mainly to Kupffer cells (Table 4 ).
In situ hybridization and immunohistochemical analysis of MIF
In situ hybridization confirmed the low level of MIF expression in the livers of rats without evidence of liver injury (Fig. 2) . In animals showing the presence of necrosis and inflammation, there was a marked increase in MIF mRNA expression (Fig. 2) . The increased expression of MIF in hepatocytes confirmed the results of RT-PCR analysis. Combined in situ hybridization and immunohistochemistry showed that ED1-positive Kupffer cells were the major source of MIF (data not shown).
In the animals showing necroinflammatory changes, the level of MIF protein, detected immunohistochemically, was higher from that seen in dextrose-fed animals. In fact, in some of the animals exhibiting liver injury, the immunostaining intensity was low despite the presence of necroinflammatory changes. Because of the known association between high levels of endotoxin and loss of MIF protein expression, we divided the rats in the FE groups into those with levels of endotoxin ,50 pg/ml and .50 pg/ml at the time of killing. Of the 10 animals fed FE, 6 had a level of .50 pg/ml. The meaning staining intensity in the rats with endotoxin levels of .50 pg/ml was 1.3 (1.3 6 0.5) compared with 2.8 (2.8 6 0.4) in rats with endotoxin levels ,50 pg/ml (p , 0.05).
DISCUSSION
Over the past few years, MIF has emerged as a pivotal cytokine that plays an important role in the control of inflammatory processes. (10, (27) (28) (29) (30) MIF, originally described as a T cell cytokine, was subsequently found to be produced by macrophages and monocytes in response to endotoxin. (10) Once released, MIF induces the expression of other proinflammatory mediators, thereby promoting and amplifying the inflammatory response. (10) The results of the present study indicate that upregulation of MIF occurs in association with inflammatory changes in the liver and coincides with increased levels of endotoxin and lipid peroxidation and upregulation of TNF-a and IFN-g. Our hypothesis is that upregulation of MIF, TNF-a, and IFNg, which occurs in association with endotoxemia and lipid peroxidation, promotes necroinflammatory changes in alcoholic liver injury. TNF-a levels are increased in both experimental and human ALD, (25, 31) and TNF-a contributes to inflammatory changes in the liver. (32) An important function of IFN-g is modulation of cytokine production. (24) IFN-g induces TNF-a synthesis and also production of other proinflammatory cytokines, such as interleukin-12. (33) The mechanism regulating TNF-a, and IFN-g production in necroinflammatory liver injury, however, remains unclear. In vitro, MIF directly induces TNF-a and IFN-g production, (34) demonstrating that MIF is a key molecule responsible for TNF-a and IFN-g production by macrophages. Unlike TNF-a and IFN-g, which are inducible, MIF is preformed. It is very possible that MIF is rapidly released from the intracellular store of both Kupffer cells and hepatocytes after alcoholic stress. Once released, MIF acts as the first proinflammatory cytokine to induce TNF-a and IFN-g expression. Therefore, MIF may play a key pathogenic role in liver inflammation.
To examine MIF production by individual cell types, hepatocytes, endothelial cells, and Kupffer cells were isolated from rats in the different experimental groups. Increased expression of MIF was seen in all cell types in the livers of alcohol-fed rats showing evidence of pathologic liver injury (MFE and FFE). By in situ hybridization and immunostaining, Kupffer cells were shown to be the major MIF-producing cells, consistent with the functional role of this cell in the liver inflammatory response. MIF secreted by nonmacrophage-type cells, such as hepatocytes, can halt macrophage migration and promote macrophage accumulation in the vicinity of MIF-producing cells. It is noteworthy that increased levels of MIF production by hepatocytes correlated with inflammatory changes. The increased levels of MIF, TNF-a, and IFN-g in the Kupffer cell are consistent with previous observations that describe a major role for the Kupffer cell in alcoholic liver injury. (5) The Kupffer cell is the predominant immune and inflammatory effector cell in the liver and, in response to such stimuli as endotoxin and lipid peroxidation, generates proinflammatory stimuli, such as cytokines and eicosanoids. MIF may also promote hepatic stellate cell proliferation by increasing production of such growth factors as platelet-derived growth factor. (35) The direct link between MIF and secretion of growth factors by hepatic stellate cells remains to be established.
The increase in MIF mRNA without an accompanying increase in MIF protein suggests that MIF exists as a preformed protein in the liver and is rapidly released on stimulation. (10, 27) Resident macrophages in the liver respond to endotoxin by increasing the mRNA levels, although not that of MIF protein.
In fact, MIF immunostaining in most tissues in endotoxintreated rats is weak, suggesting loss of MIF protein into the circulation. (10) Our results show depleted levels of immunoreactive MIF protein and increased MIF mRNA in rats with the higher levels of endotoxin, suggesting release of preformed MIF into the circulation. These results are consistent with observations showing that an abrupt loss of MIF protein in liver occurs 6 h after endotoxin administration, and by 24 h, immunoreactivity to MIF is restored. (10) As a possible explanation for the variability of endotoxin-mediated loss of MIF immunoreactivity in our study, it is well known that in rats fed ethanol intragastrically, a cycling of endotoxin levels is observed. (9) Thus, the variability of endotoxin levels seen in the rats at death probably reflects the cycling of endotoxin in blood, and loss of MIF immunostaining in rats with the higher endotoxin levels is consistent with endotoxin-mediated release of preformed MIF.
Recent observations made in our laboratory also provide additional insights into the mechanism that may account for MIFmediated effects in alcoholic liver injury. MIF stimulates phospholipase A 2 activity and arachidonic acid release, suggesting the possibility that the arachidonic acid-eicosanoid pathway is an important component of MIF-mediated effects. (36) We have previously shown increased phospholipase and cyclooxygenase-2 activities in ethanol-fed rats exhibiting pathologic liver injury. (20) In conjunction with previous studies in the intragastric feeding rat model for alcoholic liver injury, which show an increase in the levels of proinflammatory cytokines and eicosanoids, the results of the present study assign a critical role for MIF in the pathogenesis of alcoholic liver injury.
In conclusion, our results suggest that MIF is an important mediator of the inflammatory response in ALD. Given the central role of MIF in the immune response, MIF is an attractive therapeutic target in the treatment of inflammatory liver injury.
